Interferon-based agents for current and future viral respiratory infections: A scoping literature review of human studies.
The interferon (IFN) system is a potent line of defense against viral infections. IFN-based agents already tested may be of use in COVID-19 or future viral respiratory outbreaks. Here we review the comparative efficacy, safety/tolerability, and future potential of IFN-based therapeutics. We reviewed...
Saved in:
Main Authors: | Aldina Mesic, Emahlea K Jackson, Mathias Lalika, David M Koelle, Rena C Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLOS Global Public Health |
Online Access: | https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0000231&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Chronic Viral Hepatitis with Alpha-Interferon: A Consensus Conference Report
by: The CASL Hepatitis Consensus Group
Published: (1994-01-01) -
Interferon-Stimulated Genes and Immune Metabolites as Broad-Spectrum Biomarkers for Viral Infections
by: Chien-Hsin Huang, et al.
Published: (2025-01-01) -
The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
by: Cássia Milena de Souza, et al.
Published: (2025-01-01) -
MHC Class I Molecules Exacerbate Viral Infection by Disrupting Type I Interferon Signaling
by: Simo Xia, et al.
Published: (2019-01-01) -
Face Masks and Prevention of Respiratory Viral Infections: An Overview
by: Chiu-Sen Wang
Published: (2022-12-01)